Hov, Johannes R.

Genome-wide association analysis identifies variation in vitamin D receptor and other host factors influencing the gut microbiota

Wang, J., Thingholm, L. B., Skiecevičienė, J., Rausch, P., Kummen, M., Hov, J. R., Degenhardt, F., Heinsen, F.-A., Rühlemann, M. C., Szymczak, S., et al. (2016) · Nature Genetics

Gut microbiota and healthGenetic Associations and Epidemiology

Cited by 625

Microbiota‐dependent metabolite trimethylamine‐N‐oxide is associated with disease severity and survival of patients with chronic heart failure

Trøseid, M., Ueland, T., Hov, J. R., Svardal, A., Gregersen, I., Dahl, C. P., Aakhus, S., Gude, E., Bjørndal, B., Halvorsen, B., et al. (2015) · Journal of Internal Medicine

Gut microbiota and healthHeart Failure Treatment and Management

Cited by 464

The gut microbial profile in patients with primary sclerosing cholangitis is distinct from patients with ulcerative colitis without biliary disease and healthy controls

Kummen, M., Holm, K., Anmarkrud, J. A., Nygård, S., Vesterhus, M., Høivik, M. L., Trøseid, M., Marschall, H.-U., Schrumpf, E., Moum, B., et al. (2017) · Gut

Gut microbiota and healthLiver Diseases and Immunity

Cited by 426

Dense genotyping of immune-related disease regions identifies nine new risk loci for primary sclerosing cholangitis

The UK-PSCSC Consortium, Liu, J. Z., The International IBD Genetics Consortium, The International PSC Study Group, Hov, J. R., Folseraas, T., Ellinghaus, E., Rushbrook, S. M., Doncheva, N. T., Andreassen, O. A., et al. (2013) · Nature Genetics

Liver Diseases and ImmunityGenetic Associations and Epidemiology

Cited by 391

Gut Microbiota Signature in Heart Failure Defined From Profiling of 2 Independent Cohorts

Kummen, M., Mayerhofer, C. C. K., Vestad, B., Broch, K., Awoyemi, A., Storm-Larsen, C., Ueland, T., Yndestad, A., Hov, J. R., & Trøseid, M. (2018) · Journal of the American College of Cardiology

Gut microbiota and healthHeart Failure Treatment and Management

Cited by 227

Prevalence of sclerosing cholangitis detected by magnetic resonance cholangiography in patients with long-term inflammatory bowel disease

Lunder, A. K., Hov, J. R., Borthne, A., Gleditsch, J., Johannesen, G., Tveit, K., Viktil, E., Henriksen, M., Hovde, Ø., Huppertz-Hauss, G., et al. (2016) · Gastroenterology

Liver Diseases and ImmunityInflammatory Bowel Disease

Cited by 212

Autoantibodies in primary sclerosing cholangitis

Hov, J. R., Boberg, K. M., & Karlsen, T. H. (2008) · World Journal of Gastroenterology

Liver Diseases and ImmunityIgG4-Related and Inflammatory Diseases

Cited by 187

Alterations of the bile microbiome in primary sclerosing cholangitis

Liwinski, T., Zenouzi, R., John, C., Ehlken, H., Rühlemann, M. C., Bang, C., Groth, S., Lieb, W., Kantowski, M., Andersen, N., et al. (2020) · Gut

Liver Diseases and ImmunityGut microbiota and health

Cited by 149

Enhanced liver fibrosis score predicts transplant-free survival in primary sclerosing cholangitis

Vesterhus, M., Hov, J. R., Holm, A., Schrumpf, E., Nygård, S., Godang, K., Andersen, I. M., Næss, S., Thorburn, D., Saffioti, F., et al. (2015) · Hepatology

Liver Diseases and ImmunityLiver Disease Diagnosis and Treatment

Cited by 138

Altered gut microbial metabolism of essential nutrients in primary sclerosing cholangitis

Kummen, M., Thingholm, L. B., Rühlemann, M. C., Holm, K., Hansen, S. H., Moitinho-Silva, L., Liwinski, T., Zenouzi, R., Storm-Larsen, C., Midttun, Ø., et al. (2021) · Gastroenterology

Gut microbiota and healthLiver Diseases and Immunity

Cited by 129

Downregulation of TGR5 (GPBAR1) in biliary epithelial cells contributes to the pathogenesis of sclerosing cholangitis

Reich, M., Spomer, L., Klindt, C., Fuchs, K., Stindt, J., Deutschmann, K., Höhne, J., Liaskou, E., Hov, J. R., Karlsen, T. H., et al. (2021) · Journal of Hepatology

Liver Diseases and ImmunityDrug Transport and Resistance Mechanisms

Cited by 121

FUT2 and FUT3 genotype determines CA19-9 cut-off values for detection of cholangiocarcinoma in patients with primary sclerosing cholangitis

Wannhoff, A., Hov, J. R., Folseraas, T., Rupp, C., Friedrich, K., Anmarkrud, J. A., Weiss, K. H., Sauer, P., Schirmacher, P., Boberg, K. M., et al. (2013) · Journal of Hepatology

Cholangiocarcinoma and Gallbladder Cancer StudiesLiver Diseases and Immunity

Cited by 94

The kinetics of gut microbial community composition in patients with irritable bowel syndrome following fecal microbiota transplantation

Mazzawi, T., Lied, G. A., Sangnes, D. A., El-Salhy, M., Hov, J. R., Gilja, O. H., Hatlebakk, J. G., & Hausken, T. (2018) · PLoS ONE

Gastrointestinal motility and disordersGut microbiota and health

Cited by 92

Major Increase in Microbiota-Dependent Proatherogenic Metabolite TMAO One Year After Bariatric Surgery

Trøseid, M., Hov, J. R., Nestvold, T. K., Thoresen, H., Berge, R. K., Svardal, A., & Lappegård, K. T. (2016) · Metabolic Syndrome and Related Disorders

Gut microbiota and healthBariatric Surgery and Outcomes

Cited by 84

Enhanced liver fibrosis test predicts transplant-free survival in primary sclerosing cholangitis, a multi-centre study

de Vries, E. M. G., Färkkilä, M., Milkiewicz, P., Hov, J. R., Eksteen, B., Thorburn, D., Chazouillères, O., Pares, A., Nygård, S., Gilja, O. H., et al. (2017) · Liver International

Liver Diseases and ImmunityLiver Disease Diagnosis and Treatment

Cited by 83

Anti-GP2 IgA autoantibodies are associated with poor survival and cholangiocarcinoma in primary sclerosing cholangitis

Jendrek, S. T., Gotthardt, D., Nitzsche, T., Widmann, L., Korf, T., Michaels, M. A., Weiss, K.-H., Liaskou, E., Vesterhus, M., Karlsen, T. H., et al. (2017) · Gut

Liver Diseases and ImmunityInflammatory Bowel Disease

Cited by 83

The gut microbial influence on cholestatic liver disease

Kummen, M., & Hov, J. R. (2019) · Liver International

Liver Diseases and ImmunityGut microbiota and health

Cited by 74

The Microbiome in Primary Sclerosing Cholangitis: Current Evidence and Potential Concepts

Hov, J., & Karlsen, T. (2017) · Seminars in Liver Disease

Liver Diseases and ImmunityGut microbiota and health

Cited by 65

Small duct primary sclerosing cholangitis without inflammatory bowel disease is genetically different from large duct disease

Næss, S., Björnsson, E., Anmarkrud, J. A., Mamari, S. A., Juran, B. D., Lazaridis, K. N., Chapman, R., Bergquist, A., Melum, E., Marsh, S. G. E., et al. (2014) · Liver International

Liver Diseases and ImmunityInflammatory Bowel Disease

Cited by 54

Lysyl oxidase-like protein 2 (LOXL2) modulates barrier function in cholangiocytes in cholestasis

Pollheimer, M. J., Racedo, S., Mikels-Vigdal, A., Marshall, D., Bowlus, C., Lackner, C., Madl, T., Karlsen, T. H., Hov, J. R., Lyman, S. K., et al. (2018) · Journal of Hepatology

Liver Diseases and ImmunityLiver physiology and pathology

Cited by 38

Inflammation but not biliary obstruction is associated with carbohydrate antigen 19-9 levels in patients with primary sclerosing cholangitis

Wannhoff, A., Rupp, C., Friedrich, K., Brune, M., Knierim, J., Flechtenmacher, C., Sauer, P., Stremmel, W., Hov, J. R., Schirmacher, P., et al. (2015) · Clinical Gastroenterology and Hepatology

Liver Diseases and ImmunityGallbladder and Bile Duct Disorders

Cited by 34

Gut microbiota diversity is prognostic and associated with benefit from chemo-immunotherapy in metastatic triple-negative breast cancer

Ullern, A., Holm, K., Røssevold, A. H., Andresen, N. K., Bang, C., Lingjærde, O. C., Naume, B., Hov, J. R., & Kyte, J. A. (2025) · Molecular Oncology

Gut microbiota and healthCancer Immunotherapy and Biomarkers

Cited by 25

OS-076-YI Bile extracellular vesicles hold protein biomarkers for the early diagnosis of cholangiocarcinoma in individuals with primary sclerosing cholangitis

Lapitz, A., Grimsrud, M., Rodrigues, P. M., Hov, J. R., Vesterhus, M., Azkargorta, M., Grzyb, K., Reims, H. M., Elortza, F., Izquierdo-Sánchez, L., et al. (2024) · Journal of Hepatology

Extracellular vesicles in diseaseCholangiocarcinoma and Gallbladder Cancer Studies

Cited by 1